Anti-Arrhythmic Effect of Amiodarone Against Salbutamol and Aminophylline
Keywords:
Tachycardia, Salbutamol, Aminophylline, and Amiodarone.Abstract
Tachycardia refers to an abnormally fast resting heart rate. The higher-than-normal heartbeat means there is an increase in demand for oxygen by the myocardium (heart muscle) - if this persists it can lead to myocardial infarction. There are many causes to tachycardia, and one of them is the using of ant- asthmatic drugs like salbutamol and aminophylline which are well defined to cause tachycardia. This study Used the amiodaron to overcome tachycardia that associated with use of salbutamol and aminophylline. A group of 18 New Zealand rabbits were subdivided into 3 groups; first group (G1) was control, second group (G2) was salbutamol group, and the third group (G3) was aminophylline group. G2 and G3 received salbutamol and aminophylline respectively for one day, and then administered salbutamol plus amiodaron and aminophylline plus amiodaron respectively at another day, all the drugs were administered intravenously at dose (1mg\kg). The parameters are heart rate, respiratory rate and arterial oxygen tension which were measured in each group and after 15,30,60,90,120 minutes of administration. The results shows that when salbutamol and aminophylline used alone they caused increasing in heart rate and there was a highly significant difference (P<0.01) than normal. While the mixing of amiodarone with them, the heart rate was near to normal and there was non significant difference (P>0.05).
References
Boon NA, Cumming AD, and John G (2007): Davidson,s principles and practice of medicine. (Disorders of heart rate, rhythm, and conduction). 20th . ed. Elsevier Inc. Pp; 560-575.
Guyton AC, and Hall JE (2006): Textbook of Medical Physiology-Cardiac Arrhythmias and Their Electrocardiographic Interpretation. 11th ed. Saunders Philadelphia, chapter 13.
Michael C, White JC, and Song JS (2009): Cardiac arrhythmias. In Koda K., Mary A.; Young, Y. Applied Therapeutics: The Clinical Use of Drugs, 9th. ed. Lippincott Williams & Wilkins. Chapter 19.
Homer A, Boushey MD (2007): Drugs Used in Asthma. In: Katzung B.G. Basic and Clinical Pharmacology. 9th ed. McGraw Hill. Boston. Pp;315-350.
Bennett PN, Brown MJ (2003): Clinical pharmacology.9th ed. Churchill, Livingstone. London. Pp; 578-585.
Timothy HS, Cary RC, Christopher KF (2009): Asthma. In Koda K., Mary A.; Young, Y, Applied Therapeutics: The Clinical Use of Drugs, 9th. ed. Lippincott Williams & Wilkins. Chapter 22.
Brunton L, and Parker K (2008): Goodman and Gillman
Salbutamol. From Wikipedia, free encyclopedia. 2013.
Aminophylline. From Wikipedia, free encyclopedia. 2013.
Joseph RH, and Augustus OG (2007): Agents Used in Cardiac Arrhythmias. In: Katzung BG, Basic and Clinical Pharmacology. 9th ed. McGraw Hill. Boston. Pp; 211-235.
Brunton L, and Parker K (2008): Goodman and Gillman
Amiodarone. From Wikipedia, free encyclopedia. 2013
Mokra D, Drgova A, and MokryJ (2008): Combination of Budesonide and Aminophylline diminished acute lung injury in animal model of meconium aspiration syndrome. Journal of physiology and pharmacology. 59 (6). Pp; 461-471.
Mohammed AA, Sayed MA, Abdelnabi MA (2011): A New Protocol of Anesthesia Using Thiopental, Diazepam and Xylazine in White New Zealand Rabbits. Australian Journal of Basic and Applied Sciences, 5(9). Pp; 1296-1300.
Daniel WW (1983): Biostatistics: A foundation for analysis in the health sciences. 3rd rd. John Wiley and Sons. New York. Pp. 89-92, 102-103.
Newnham D (2001): Asthma medications and their potential adverse effects in the elderly: recommendations for prescribing. 24 (14). Pp; 1065-80. pubmed.gov.
Gupta P, O'Mahony MS (2008): Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing. 25(5):415- 43. pubmed.gov.
Barua P, O'Mahony MS (2005): Overcoming gaps in the management of asthma in older patients: new insights. 22(12):1029-59. pubmed.gov.
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Authors who submit papers with this journal agree to the following terms.